Brancaleone P, Descamps O, Piquet M, Detry G, Mignon M, Weynand B
Service de pneumologie, centres hospitaliers Jolimont, 7100 La Louvière, Belgique.
Service de médecine interne, centres hospitaliers Jolimont, 7100 La Louvière, Belgique.
Rev Mal Respir. 2021 Feb;38(2):210-214. doi: 10.1016/j.rmr.2020.11.012. Epub 2021 Feb 10.
Sertraline is a selective serotonin reuptake inhibitor which is often used as first-line treatment for depression. Several patterns of interstitial lung disease attributable to sertraline have been reported in the literature.
A 69-year-old patient, who had been taking sertraline to treat severe depression for 10 months, presented with a deterioration in his general condition and respiratory symptoms found to be associated with bilateral pneumonitis. An exhaustive assessment did not reveal any infectious or autoimmune aetiology. Transthoracic lung biopsy revealed a pattern of eosinophilic lung disease. Sertraline-induced lung toxicity was then suspected and this treatment was therefore stopped. The patient's symptoms resolved and the chest imaging normalized.
Our observation suggests that sertraline was the cause of chronic eosinophilic pneumonia characterized by an insidious clinical presentation several months after starting the medication. Given its widespread prescription, we encourage any clinician facing this disease to pay attention to possible drug-induced origins of lung disease.
舍曲林是一种选择性5-羟色胺再摄取抑制剂,常用于抑郁症的一线治疗。文献中已报道了几种由舍曲林引起的间质性肺病模式。
一名69岁患者,服用舍曲林治疗重度抑郁症10个月,出现全身状况恶化及呼吸症状,发现与双侧肺炎有关。全面评估未发现任何感染性或自身免疫性病因。经胸肺活检显示为嗜酸性肺病模式。于是怀疑是舍曲林引起的肺毒性,因此停用了该治疗。患者症状缓解,胸部影像学恢复正常。
我们的观察表明,舍曲林是慢性嗜酸性肺炎的病因,其临床表现隐匿,在开始用药数月后出现。鉴于其广泛的处方应用,我们鼓励任何面对这种疾病的临床医生关注可能的药物性肺病病因。